COMPANY - MERCK CO INC,MRK
NEWS - Merck & Co,on Thursday said U.S. regulators had widened the approved use of its Isentress HIV treatment to include patients who have not yet been treated for infections with the virus that causes AIDS.Isentress, the only approved member of a new family of anti-HIV medicines known as integrase inhibitors, has been available since late 2007 for patients who have failed to benefit from prior treatment with HIV medicines.
ABOUT - Merck & Co., Inc. provides products for human and animal health in the
After Hours: 26.45 0.00 (0.00%) 4:52PM ET
Last Trade: 26.45
Day's Range: 0.00 - 0.00
52wk Range: 20.05 - 38.34
Volume: 17,947,760
---
WhisperFromWallStreet is a news letter focusing on sending specific alerts to our subscribers. These alerts represent which stocks we believe are going to run. Additionally we spend time teaching how to become a better trader. If you like more information or to Sign Up for free alerts, visit us at WhisperfromWallStreet.com
Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php
IMPORTANT INFORMATION: Nothing in this press release should be interpreted as a solicitation to buy any stock or security represented herein. WhisperfromWallStreet, nor any of its affiliates are registered investment advisors or broker dealers. Information presented here is based on our opinion only.
